⌘K

Home/Filings/4/0000899243-20-025035

4//SEC Filing

Kaplan Brett 4

Accession 0000899243-20-025035

CIK 0001738021other

View on SEC.gov Company Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 8:02 PM ET

Size

5.4 KB

Accession

0000899243-20-025035

Insider Transaction Report

Form 4

Period: 2020-09-10

Compass Therapeutics, Inc.NONE

Director

Transactions

Award
Stock Option (Right to Buy)
2020-09-10+60,000→ 60,000 total
Exercise: $5.00Exp: 2030-09-10→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]This option shall vest in substantially equal monthly installments over four years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1

filerCIK 0001778763

Filing Metadata

Form type: 4
Filed: Sep 13, 8:00 PM ET
Accepted: Sep 14, 8:02 PM ET
Size: 5.4 KB

View on SEC.gov